Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies.
Leto, Simonetta M
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies. [electronic resource] - Journal of molecular medicine (Berlin, Germany) Jul 2014 - 709-22 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1432-1440
10.1007/s00109-014-1161-2 doi
Animals
Antibodies, Monoclonal--therapeutic use
Antineoplastic Agents--therapeutic use
Biomarkers, Tumor--metabolism
Colorectal Neoplasms--drug therapy
Drug Resistance, Neoplasm
Humans
Protein-Tyrosine Kinases--antagonists & inhibitors
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies. [electronic resource] - Journal of molecular medicine (Berlin, Germany) Jul 2014 - 709-22 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1432-1440
10.1007/s00109-014-1161-2 doi
Animals
Antibodies, Monoclonal--therapeutic use
Antineoplastic Agents--therapeutic use
Biomarkers, Tumor--metabolism
Colorectal Neoplasms--drug therapy
Drug Resistance, Neoplasm
Humans
Protein-Tyrosine Kinases--antagonists & inhibitors